CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- Open-market buys, last 90 days
- $99,331
- in 1 filing
- Open-market sales, last 90 days
- $378,930
- in 4 filings, $379K under 10b5-1 plans
Net −$279,599. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-22 | COSTA SANTO J Director | Grant or award · Stock Option (Right to Purchase) | +25,000 | 25,000 | ||
| 2022-06-14 | Boyd Peter E. SVP-Bus. Process & Info. Tech. | Purchase | +5,000 | $0.81 | $4K | 59,532 |
| 2022-06-08 | Barber Daniel Chief Executive Officer | Purchase | +91,743 | $0.96 | $88K | 193,702 |
| 2022-06-08 | Barber Daniel Chief Executive Officer | Purchase · Warrant (Right to Buy) | +91,743 | $0.13 | $12K | 91,743 |
| 2022-06-08 | Schobel Alexander Mark Chief Innovation/Tech Officer | Purchase | +45,871 | $0.96 | $44K | 882,871 |
| 2022-06-08 | Schobel Alexander Mark Chief Innovation/Tech Officer | Purchase · Warrant (Right to Buy) | +45,871 | $0.13 | $6K | 45,871 |
| 2022-06-08 | Boyd Peter E. SVP-Bus. Process & Info. Tech. | Purchase | +2,293 | $0.96 | $2K | 54,532 |
| 2022-06-08 | Boyd Peter E. SVP-Bus. Process & Info. Tech. | Purchase · Warrant (Right to Buy) | +2,293 | $0.13 | $298 | 2,293 |
| 2022-06-08 | BRAENDER LORI J General Counsel | Purchase | +13,761 | $0.96 | $13K | 38,761 |
| 2022-06-08 | BRAENDER LORI J General Counsel | Purchase · Warrant (Right to Buy) | +13,761 | $0.13 | $2K | 13,761 |
| 2022-03-10 | Barber Daniel SVP-Chief Operating Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +225,000 | 225,000 | ||
| 2022-03-10 | Wood Theresa SVP-HR and Org. Development | Grant or award · Non-Qualified Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2022-03-10 | TOTH A ERNEST JR Interim CFO | Grant or award · Non-Qualified Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2022-03-10 | Schobel Alexander Mark Chief Innovation/Tech Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2022-03-10 | Marshall Ken W. SVP, Chief Commercial Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2022-03-10 | BRAENDER LORI J SVP, General Counsel | Grant or award · Non-Qualified Stock Option (right to buy) | +160,000 | 160,000 | ||
| 2022-03-10 | Boyd Peter E. SVP-Bus. Process & Info. Tech. | Grant or award · Non-Qualified Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2022-03-10 | Kendall Keith J CEO and President | Grant or award · Non-Qualified Stock Option (right to buy) | +375,000 | 375,000 | ||
| 2021-08-26 | Kendall Keith J CEO and President | Gift | −1,000 | 636,149 | ||
| 2021-08-26 | Kendall Keith J CEO and President | Gift | +1,000 | 1,000 |
Page 12 of 24 · 462 trades